Well, we let this poll go on a little bit longer than normal hoping that one of the choices would pull away from the other. But alas, the split has been nearly equal since the poll has been up. There have been many predictions on the Death of Microarrays but it seems they may be here to stay.
The future of microarrays?
Here to stay (i.e. Affy and Agilent affirm continued commitment) (50%, 88 Votes)
Its curtains (i.e. Roche shuts down Nimblegen, Combimatrix trading at $0.85) (50%, 87 Votes)
Total Voters: 175
Check out our latest poll in the left-hand sidebar and cast your vote.